Cedars-Sinai Medical Center and AIkido Pharma Inc. Enter Into Master Collaboration Agreement

Provided By PR Newswire

Last update: Mar 8, 2022

NEW YORK, March 8, 2022 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the Company has entered into a Master Collaboration Agreement (MCA) with Cedars-Sinai Medical Center. The purpose of the MCA is to collaborate in the funding and commercialization of discoveries and technologies developed at Cedars-Sinai.